The Enteric Disease Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Reagents and Consumables, Equipment), By Technique (Molecular Diagnostics, Immunodiagnostics), By Disease Type (Bacterial Enteric Disease, Viral Enteric Disease, Parasitic Enteric Disease), By End-User (Academic and Research Institutes, Hospital Laboratories, Pharmaceutical and Biotechnology Companies).
The enteric disease testing market in 2024 addresses the demand for diagnostic tests and assays used to detect and identify infectious agents, pathogens, and biomarkers associated with enteric diseases and gastrointestinal infections, including bacterial, viral, and parasitic pathogens transmitted through contaminated food, water, and fecal-oral routes. Enteric disease testing encompasses a wide range of laboratory techniques such as culture-based methods, molecular diagnostics (PCR, qPCR), immunoassays, and rapid antigen tests, targeting pathogens such as Salmonella, Escherichia coli (E. coli), norovirus, and Clostridium difficile (C. diff), as well as inflammatory markers and fecal occult blood for the diagnosis and management of gastroenteritis, foodborne illnesses, and inflammatory bowel diseases (IBD). Market dynamics are driven by factors such as the increasing incidence of enteric infections, the growing demand for rapid and accurate diagnostic tests, and advancements in enteric disease surveillance, outbreak investigation, and public health interventions for improved disease control and prevention. Collaboration between enteric disease test manufacturers, clinical laboratories, and public health agencies drives innovation and market expansion in enteric disease testing, supporting early detection, treatment optimization, and infectious disease control strategies in gastroenterology and public health.
A significant trend in the Enteric Disease Testing market is the increasing adoption of rapid molecular diagnostics technologies for the detection and identification of enteric pathogens. Traditional methods for enteric disease testing, such as culture-based techniques, often require prolonged incubation periods and may lack sensitivity and specificity, leading to delays in diagnosis and treatment. In contrast, molecular diagnostic assays, including polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), offer rapid and accurate detection of enteric pathogens, enabling healthcare providers to promptly diagnose infections, implement appropriate treatment strategies, and mitigate the spread of infectious diseases. As healthcare systems prioritize timely diagnosis and surveillance of enteric diseases, there is a growing demand for molecular diagnostic platforms that offer multiplexing capabilities, high throughput, and point-of-care testing options, driving market growth in this segment.
A key driver in the Enteric Disease Testing market is the rising incidence of foodborne and waterborne illnesses globally, necessitating effective diagnostic solutions to identify the causative agents and prevent outbreaks. Enteric diseases, such as salmonellosis, campylobacteriosis, and norovirus gastroenteritis, pose significant public health challenges, leading to substantial morbidity, mortality, and economic burden worldwide. With the globalization of food supply chains, changes in agricultural practices, and environmental factors, the risk of enteric infections remains prevalent, underscoring the importance of robust diagnostic capabilities for timely intervention and disease control. Healthcare providers, regulatory agencies, and food safety authorities are increasingly focusing on surveillance, outbreak investigation, and preventive measures, driving the demand for enteric disease testing solutions that offer rapid, reliable, and comprehensive pathogen detection capabilities to safeguard public health.
An opportunity for growth in the Enteric Disease Testing market lies in the development of multiplex molecular assays and point-of-care testing (POCT) platforms for decentralized testing and surveillance. Multiplex molecular assays capable of detecting multiple enteric pathogens simultaneously offer advantages in terms of efficiency, cost-effectiveness, and resource utilization, enabling healthcare providers to streamline testing workflows, conserve laboratory resources, and expedite diagnostic turnaround times. Additionally, there is a growing demand for POCT solutions that can be deployed in various healthcare settings, including clinics, emergency departments, and remote areas, to facilitate rapid diagnosis and decision-making at the point of care. By investing in research and development initiatives focused on developing multiplex molecular assays and portable POCT platforms, manufacturers can address unmet needs in enteric disease testing, expand market reach, and capitalize on the growing demand for decentralized diagnostic solutions in the evolving landscape of infectious disease management.
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott
Becton, Dickinson and Company
Biomerica
BIOMÉRIEUX
Bio-Rad Laboratories Inc
Cepheid
Coris BioConcept
DiaSorin S.p.A.
Meridian Bioscience
Quest Diagnostics Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Enteric Disease Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Enteric Disease Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Enteric Disease Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Enteric Disease Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Enteric Disease Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Enteric Disease Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Enteric Disease Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Enteric Disease Testing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Enteric Disease Testing Market Industry
4.2 Key Market Trends in Enteric Disease Testing Market Industry
4.3 Potential Opportunities in Enteric Disease Testing Market Industry
4.4 Key Challenges in Enteric Disease Testing Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Enteric Disease Testing Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Enteric Disease Testing Market Outlook By Segments
7.1 Enteric Disease Testing Market Outlook by Segments
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
8 North America Enteric Disease Testing Market Analysis And Outlook To 2030
8.1 Introduction to North America Enteric Disease Testing Markets in 2024
8.2 North America Enteric Disease Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Enteric Disease Testing Market size Outlook by Segments, 2021-2030
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
9 Europe Enteric Disease Testing Market Analysis And Outlook To 2030
9.1 Introduction to Europe Enteric Disease Testing Markets in 2024
9.2 Europe Enteric Disease Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Enteric Disease Testing Market Size Outlook By Segments, 2021-2030
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
10 Asia Pacific Enteric Disease Testing Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Enteric Disease Testing Markets in 2024
10.2 Asia Pacific Enteric Disease Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Enteric Disease Testing Market size Outlook by Segments, 2021-2030
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
11 South America Enteric Disease Testing Market Analysis And Outlook To 2030
11.1 Introduction to South America Enteric Disease Testing Markets in 2024
11.2 South America Enteric Disease Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Enteric Disease Testing Market size Outlook by Segments, 2021-2030
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
12 Middle East And Africa Enteric Disease Testing Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Enteric Disease Testing Markets in 2024
12.2 Middle East and Africa Enteric Disease Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Enteric Disease Testing Market size Outlook by Segments, 2021-2030
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Becton, Dickinson and Company
Biomerica
BIOMÉRIEUX
Bio-Rad Laboratories Inc
Cepheid
Coris BioConcept
DiaSorin S.p.A.
Meridian Bioscience
Quest Diagnostics Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Enteric Disease Testing Market is one of the lucrative growth markets, poised to register a 4.1% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Becton, Dickinson and Company, Biomerica, BIOMÉRIEUX, Bio-Rad Laboratories Inc, Cepheid, Coris BioConcept, DiaSorin S.p.A., Meridian Bioscience, Quest Diagnostics Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume